Vaccines | Notable Papers Published in 2025 in the “Vaccine Design, Development, and Delivery” Section
1. “Lipoprotein Signal Peptide as Adjuvants: Leveraging Lipobox-Driven TLR2 Activation in Modern Vaccine Design”
by Muhammad Umar, Haroon Afzal, Asad Murtaza and Li-Ting Cheng
Vaccines 2025, 13(1), 36; https://doi.org/10.3390/vaccines13010036
Full text available online: https://www.mdpi.com/2076-393X/13/1/36
2. “Immunization with Complete Freund’s Adjuvant Reveals Trained Immunity-like Features in A/J Mice”
by Kiruthiga Mone, Shraddha Singh, Fatema Abdullatif, Meghna Sur, Mahima T. Rasquinha, Javier Seravalli, Denise K. Zinniel, Indranil Mukhopadhyay, Raul G. Barletta, Teklab Gebregiworgis and Jay Reddy
Vaccines 2025, 13(7), 768; https://doi.org/10.3390/vaccines13070768
Full text available online: https://www.mdpi.com/2076-393X/13/7/768
3. “Sex and Age-Based Differences in Immune Responses to a Peptide Vaccine for Melanoma in Two Clinical Trials”
by Serena M. Vilasi and Craig L. Slingluff, Jr.
Vaccines 2025, 13(2), 194; https://doi.org/10.3390/vaccines13020194
Full text available online: https://www.mdpi.com/2076-393X/13/2/194
4. “Inflammatory and Humoral Immune Responses to Commercial Autogenous Salmonella Bacterin Vaccines in Light-Brown Leghorn Pullets: Primary and Secondary Vaccine Responses”
by Chrysta N. Beck, Jossie M. Santamaria and Gisela F. Erf
Vaccines 2025, 13(3), 311; https://doi.org/10.3390/vaccines13030311
Full text available online: https://www.mdpi.com/2076-393X/13/3/311
5. “A Nanoparticle Comprising the Receptor-Binding Domains of Norovirus and Plasmodium as a Combination Vaccine Candidate”
by Ming Xia, Pengwei Huang, Frank S. Vago, Wen Jiang, Xi Jiang and Ming Tan
Vaccines 2025, 13(1), 34; https://doi.org/10.3390/vaccines13010034
Full text available online: https://www.mdpi.com/2076-393X/13/1/34
6. “Bovine Adenoviral Vector-Based Platform for Vaccine Development”
by Ekramy E. Sayedahmed, Vivek Gairola, Muralimanohara S. T. Murala and Suresh K. Mittal
Vaccines 2025, 13(5), 494; https://doi.org/10.3390/vaccines13050494
Full text available online: https://www.mdpi.com/2076-393X/13/5/494
7. “Multi-Component Vaccine Candidates Against Non-Typeable Haemophilus influenzae”
by Nouria Belkacem, Ala-Eddine Deghmane and Muhamed-Kheir Taha
Vaccines 2025, 13(9), 892; https://doi.org/10.3390/vaccines13090892
Full text available online: https://www.mdpi.com/2076-393X/13/9/892
8. “Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy”
by Majed Ghattas, Garima Dwivedi, Anik Chevrier, Trevor Scobey, Rakan El-Mayta, Melissa D. Mattocks, Dong Wang, Marc Lavertu and Mohamad-Gabriel Alameh
Vaccines 2025, 13(8), 788; https://doi.org/10.3390/vaccines13080788
Full text available online: https://www.mdpi.com/2076-393X/13/8/788
9. “Adjuvant Templating Improves On-Target/Off-Target Antibody Ratio Better than Linker Addition for M2-Derived Peptide Amphiphile Micelle Vaccines”
by Megan C. Schulte, Adam C. Boll, Natalie L. Conomos, Farnoushsadat Rezaei, Agustin T. Barcellona, Adam G. Schrum and Bret D. Ulery
Vaccines 2025, 13(4), 422; https://doi.org/10.3390/vaccines13040422
Full text available online: https://www.mdpi.com/2076-393X/13/4/422
by Sohrab Ahmadivand
Vaccines 2025, 13(6), 653; https://doi.org/10.3390/vaccines13060653
Full text available online: https://www.mdpi.com/2076-393X/13/6/653